CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28067227.
- Also identified by DOI 10.1038/ncomms13923 and PMC identifier 5228031.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tumour metastasis, the spread of cancer cells from the original tumour site followed by growth of secondary tumours at distant organs, is the primary cause of cancer-related deaths and remains poorly understood. Here we demonstrate that inhibition of CDK4/6 blocks breast tumour metastasis in the triple-negative breast cancer model, without affecting tumour growth. Mechanistically, we identify a deubiquitinase, DUB3, as a target of CDK4/6; CDK4/6-mediated activation of DUB3 is essential to deubiquitinate and stabilize SNAIL1, a key factor promoting epithelial-mesenchymal transition and breast cancer metastasis. Overall, our study establishes the CDK4/6-DUB3 axis as an important regulatory mechanism of breast cancer metastasis and provides a rationale for potential therapeutic interventions in the treatment of breast cancer metastasis.
Medical subject headings
- Cyclin-Dependent Kinase 4
- Cyclin-Dependent Kinase 6
- Endopeptidases
- Gene Expression Regulation, Neoplastic
- Liver Neoplasms
- Lung Neoplasms
- Ovarian Neoplasms
- Triple Negative Breast Neoplasms